Reporte zur Charge NG5GS

Symptomtext

an 11 year old /on 04-Aug-2021 / received a dose of / Infanrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old patient who received DTPa (Infanrix) (batch number NG5GS, expiry date 26th November 2021) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th August 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 4th August 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details provided were as follows: The patient's age at the time of vaccination was not confirmed to be 11 years but reporter commented so. The patient?s chart for an 11 year old showed that, the patient received a dose of Infanrix, which led to inappropriate age at vaccine administration. The reporter consented to follow-up.